{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:19:10Z","timestamp":1787710750917,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["20174Y0062"],"award-info":[{"award-number":["20174Y0062"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"DOI":"10.1007\/s00405-026-10573-6","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T01:43:17Z","timestamp":1787708597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasminogen activator inhibitor-1 promotes the proliferation and blocks TGF-\u03b21-dependent growth inhibition of cholesteatoma keratinocytes by ERK signaling"],"prefix":"10.1007","author":[{"given":"Linhan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa","family":"Tursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangcai","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"10573_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12105-018-0915-5","volume":"12","author":"JT Castle","year":"2018","unstructured":"Castle JT (2018) Cholesteatoma pearls: practical points and update. Head Neck Pathol 12:419\u2013429. https:\/\/doi.org\/10.1007\/s12105-018-0915-5","journal-title":"Head Neck Pathol"},{"key":"10573_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/lary.24890","volume":"125","author":"CL Kuo","year":"2015","unstructured":"Kuo CL (2015) Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope 125:234\u2013240. https:\/\/doi.org\/10.1002\/lary.24890","journal-title":"Laryngoscope"},{"key":"10573_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00405-015-3679-5","volume":"273","author":"Y Morita","year":"2016","unstructured":"Morita Y, Yamamoto Y, Oshima S, Takahashi K, Takahashi S (2016) Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma. Eur Arch Otorhinolaryngol 273:1155\u20131160. https:\/\/doi.org\/10.1007\/s00405-015-3679-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10573_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1808-8694(15)31020-X","volume":"72","author":"C Dornelles","year":"2006","unstructured":"Dornelles C, Meurer L, Selaimen da Costa S, Schweiger C (2006) Histologic description of acquired cholesteatomas: comparison between children and adults. Braz J Otorhinolaryngol 72:641\u2013648. https:\/\/doi.org\/10.1016\/s1808-8694(15)31020-x","journal-title":"Braz J Otorhinolaryngol"},{"key":"10573_CR5","doi-asserted-by":"publisher","unstructured":"Rolesi R et al. (2023) Study of angiogenic, pro-apoptotic, and pro-inflammatory factors in congenital and acquired cholesteatomas. J Pers Med 13 https:\/\/doi.org\/10.3390\/jpm13081189","DOI":"10.3390\/jpm13081189"},{"key":"10573_CR6","first-page":"987","volume":"22","author":"S Li","year":"2008","unstructured":"Li S, Zhan H, Peng S (2008) Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22:987\u2013991","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10573_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1017\/S002221511100315X","volume":"126","author":"K Sikka","year":"2012","unstructured":"Sikka K, Sharma SC, Thakar A, Dattagupta S (2012) Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker. J Laryngol Otol 126:460\u2013463. https:\/\/doi.org\/10.1017\/S002221511100315X","journal-title":"J Laryngol Otol"},{"key":"10573_CR8","first-page":"7","volume":"55","author":"A Maniu","year":"2014","unstructured":"Maniu A et al (2014) Molecular biology of cholesteatoma. Rom J Morphol Embryol 55:7\u201313","journal-title":"Rom J Morphol Embryol"},{"key":"10573_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1017\/S0022215113000601","volume":"127","author":"L Louw","year":"2013","unstructured":"Louw L (2013) Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol 127:542\u2013549. https:\/\/doi.org\/10.1017\/S0022215113000601","journal-title":"J Laryngol Otol"},{"key":"10573_CR10","doi-asserted-by":"publisher","unstructured":"Welkoborsky HJ (2011) Current concepts of the pathogenesis of acquired middle ear cholesteatoma. Laryngorhinootologie 90:38\u201348. quiz 49\u201350. https:\/\/doi.org\/10.1055\/s-0030-1268464","DOI":"10.1055\/s-0030-1268464"},{"key":"10573_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/MLG.0b013e31814faafa","volume":"118","author":"MA de Huisman","year":"2008","unstructured":"Huisman MA, de Heer E, Ten Dijke P, Grote JJ (2008) Transforming growth factor beta and wound healing in human cholesteatoma. Laryngoscope 118:94\u201398. https:\/\/doi.org\/10.1097\/MLG.0b013e31814faafa","journal-title":"Laryngoscope"},{"key":"10573_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286\u20131292. https:\/\/doi.org\/10.1056\/NEJM199411103311907","journal-title":"N Engl J Med"},{"key":"10573_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.276.5309.75","volume":"276","author":"P Martin","year":"1997","unstructured":"Martin P (1997) Wound healing\u2013aiming for perfect skin regeneration. Science 276:75\u201381. https:\/\/doi.org\/10.1126\/science.276.5309.75","journal-title":"Science"},{"key":"10573_CR14","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/jid.2010.106","volume":"130","author":"J Freytag","year":"2010","unstructured":"Freytag J et al (2010) PAI-1 mediates the TGF-beta1\u2009+\u2009EGF-induced scatter response in transformed human keratinocytes. J Invest Dermatol 130:2179\u20132190. https:\/\/doi.org\/10.1038\/jid.2010.106","journal-title":"J Invest Dermatol"},{"key":"10573_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00403-008-0845-2","volume":"300","author":"KM Providence","year":"2008","unstructured":"Providence KM et al (2008) SERPINE1 (PAI-1) is deposited into keratinocyte migration trails and required for optimal monolayer wound repair. Arch Dermatol Res 300:303\u2013310. https:\/\/doi.org\/10.1007\/s00403-008-0845-2","journal-title":"Arch Dermatol Res"},{"key":"10573_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.jid.5701068","volume":"128","author":"L Qi","year":"2008","unstructured":"Qi L et al (2008) SERPINE1 (PAI-1) is a prominent member of the early G0 G1 transition wound repair transcriptome in p53 mutant human keratinocytes. J Invest Dermatol 128:749\u2013753. https:\/\/doi.org\/10.1038\/sj.jid.5701068","journal-title":"J Invest Dermatol"},{"key":"10573_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/wound.2013.0512","volume":"3","author":"TM Simone","year":"2014","unstructured":"Simone TM et al (2014) SERPINE1: a molecular switch in the proliferation-migration dichotomy in wound-activated keratinocytes. Adv Wound Care (New Rochelle) 3:281\u2013290. https:\/\/doi.org\/10.1089\/wound.2013.0512","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10573_CR18","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.7150\/ijms.60617","volume":"18","author":"C Zhang","year":"2021","unstructured":"Zhang C, Chen M, Tao Q, Chi Z (2021) Cobalt chloride-stimulated hypoxia promotes the proliferation of cholesteatoma keratinocytes via the PI3K\/Akt signaling pathway. Int J Med Sci 18:3403\u20133411. https:\/\/doi.org\/10.7150\/ijms.60617","journal-title":"Int J Med Sci"},{"key":"10573_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jcp.20279","volume":"204","author":"R Samarakoon","year":"2005","unstructured":"Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ (2005) Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)\/MEK-dependent. J Cell Physiol 204:236\u2013246. https:\/\/doi.org\/10.1002\/jcp.20279","journal-title":"J Cell Physiol"},{"key":"10573_CR20","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1002\/cam4.4059","volume":"10","author":"D Liu","year":"2021","unstructured":"Liu D et al (2021) Trichostatin a promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4\/ERK1\/2-dependent pathway. Cancer Med 10:5235\u20135245. https:\/\/doi.org\/10.1002\/cam4.4059","journal-title":"Cancer Med"},{"key":"10573_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2217\/fon.09.90","volume":"5","author":"MK Wendt","year":"2009","unstructured":"Wendt MK, Allington TM, Schiemann WP (2009) Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 5:1145\u20131168. https:\/\/doi.org\/10.2217\/fon.09.90","journal-title":"Future Oncol"},{"key":"10573_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1593\/neo.04241","volume":"6","author":"L Xie","year":"2004","unstructured":"Xie L et al (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6:603\u2013610. https:\/\/doi.org\/10.1593\/neo.04241","journal-title":"Neoplasia"},{"key":"10573_CR23","doi-asserted-by":"publisher","first-page":"24308","DOI":"10.1074\/jbc.M803341200","volume":"283","author":"RM Kortlever","year":"2008","unstructured":"Kortlever RM, Nijwening JH, Bernards R (2008) Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity. J Biol Chem 283:24308\u201324313. https:\/\/doi.org\/10.1074\/jbc.M803341200","journal-title":"J Biol Chem"},{"key":"10573_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/ncb1448","volume":"8","author":"RM Kortlever","year":"2006","unstructured":"Kortlever RM, Higgins PJ, Bernards R (2006) Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 8:877\u2013884. https:\/\/doi.org\/10.1038\/ncb1448","journal-title":"Nat Cell Biol"},{"key":"10573_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.thromres.2012.09.003","volume":"131","author":"YP Zhang","year":"2013","unstructured":"Zhang YP et al (2013) Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling. Thromb Res 131:64\u201371. https:\/\/doi.org\/10.1016\/j.thromres.2012.09.003","journal-title":"Thromb Res"},{"key":"10573_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/j.1523-1755.2005.00207.x","volume":"67","author":"SB Nicholas","year":"2005","unstructured":"Nicholas SB et al (2005) Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int 67:1297\u20131307. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00207.x","journal-title":"Kidney Int"},{"key":"10573_CR27","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1161\/01.RES.0000266970.34017.8d","volume":"100","author":"G Otsuka","year":"2007","unstructured":"Otsuka G, Stempien-Otero A, Frutkin AD, Dichek DA (2007) Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells. Circ Res 100:1300\u20131307. https:\/\/doi.org\/10.1161\/01.RES.0000266970.34017.8d","journal-title":"Circ Res"},{"key":"10573_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/01.ATV.0000209949.86606.c2","volume":"26","author":"DE Vaughan","year":"2006","unstructured":"Vaughan DE (2006) PAI-1 and TGF-beta: unmasking the real driver of TGF-beta-induced vascular pathology. Arterioscler Thromb Vasc Biol 26:679\u2013680. https:\/\/doi.org\/10.1161\/01.ATV.0000209949.86606.c2","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10573-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T01:43:18Z","timestamp":1787708598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":28,"alternative-id":["10573"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10573-6","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was provided by all participants. Human studies complied with the principles of the Declaration of Helsinki and were approved by the Research Ethics Committee of the Eye and ENT Hospital of Fudan University. The consent form for participation and publishing was signed by the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicting interests, according to the authors.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}